{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T05:16:17Z","timestamp":1783055777058,"version":"3.54.6"},"reference-count":57,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100006342","name":"Defeating Cystic Fibrosis Association","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006342","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","cysticfibrosisjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Cystic Fibrosis"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1016\/j.jcf.2026.04.011","type":"journal-article","created":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T12:11:53Z","timestamp":1778760713000},"update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Towards a gut-lung axis role in pwCF on CFTR modulators: rationale, clinical evidence and perspectives"],"prefix":"10.1016","author":[{"ORCID":"https:\/\/orcid.org\/0009-0003-1645-0030","authenticated-orcid":false,"given":"Maxime","family":"Lefranc","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eloise","family":"Ramel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryan","family":"Marsh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-6708-3296","authenticated-orcid":false,"given":"James M","family":"Tricker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1101-4048","authenticated-orcid":false,"given":"Christopher","family":"van der Gast","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4767-6238","authenticated-orcid":false,"given":"Jennifer M.","family":"Bomberger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7489-9205","authenticated-orcid":false,"given":"Laurence","family":"Delhaes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jcf.2026.04.011_bib0001","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1038\/nrmicro3552","article-title":"Gut biogeography of the bacterial microbiota","volume":"14","author":"Donaldson","year":"2016","journal-title":"Nat Rev Microbiol"},{"key":"10.1016\/j.jcf.2026.04.011_bib0002","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.635471","article-title":"Microbiota modulation of the gut-lung axis in COVID-19","volume":"12","author":"De Oliveira","year":"2021","journal-title":"Front Immunol"},{"key":"10.1016\/j.jcf.2026.04.011_bib0003","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.jcf.2018.11.003","article-title":"The lung and gut microbiome: what has to be taken into consideration for cystic fibrosis?","volume":"18","author":"H\u00e9ry-Arnaud","year":"2019","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.jcf.2026.04.011_bib0004","doi-asserted-by":"crossref","first-page":"9","DOI":"10.3389\/fcimb.2020.00009","article-title":"The gut-lung axis in health and respiratory diseases: a place for inter-organ and inter-Kingdom crosstalks","volume":"10","author":"Enaud","year":"2020","journal-title":"Front Cell Infect Microbiol"},{"key":"10.1016\/j.jcf.2026.04.011_bib0005","doi-asserted-by":"crossref","DOI":"10.3389\/fcimb.2023.1271117","article-title":"The gut-lung axis in the CFTR modulator era","volume":"13","author":"Lussac-Sorton","year":"2023","journal-title":"Front Cell Infect Microbiol"},{"key":"10.1016\/j.jcf.2026.04.011_bib0006","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1038\/s41579-024-01048-8","article-title":"The gut-airway microbiome axis in health and respiratory diseases","volume":"22","author":"\u00d6z\u00e7am","year":"2024","journal-title":"Nat Rev Microbiol"},{"key":"10.1016\/j.jcf.2026.04.011_bib0007","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.02290-2023","article-title":"The longitudinal microbial and metabolic landscape of infant cystic fibrosis: the gut\u2013lung axis","volume":"63","author":"Frayman","year":"2024","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jcf.2026.04.011_bib0008","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1097\/NRL.0000000000000626","article-title":"Stroke-associated pneumonia and the brain-gut-lung axis: a systematic literature review","volume":"30","author":"Bai","year":"2025","journal-title":"Neurologist"},{"key":"10.1016\/j.jcf.2026.04.011_bib0009","doi-asserted-by":"crossref","first-page":"1678","DOI":"10.3389\/fimmu.2017.01678","article-title":"Protective microbiota: from localized to long-reaching Co-immunity","volume":"8","author":"Chiu","year":"2017","journal-title":"Front Immunol"},{"key":"10.1016\/j.jcf.2026.04.011_bib0010","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1016\/j.jcf.2020.12.022","article-title":"Relationship between airway dysbiosis, inflammation and lung function in adults with cystic fibrosis","volume":"20","author":"Frey","year":"2021","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.jcf.2026.04.011_bib0011","doi-asserted-by":"crossref","DOI":"10.1016\/j.medmic.2022.100057","article-title":"Intestinal dysbiosis and inflammation in cystic fibrosis impacts gut and multi-organ axes","volume":"13","author":"Wrigley-Carr","year":"2022","journal-title":"Med Microecol"},{"key":"10.1016\/j.jcf.2026.04.011_bib0012","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1038\/nrmicro.2016.142","article-title":"Emerging pathogenic links between microbiota and the gut\u2013lung axis","volume":"15","author":"Budden","year":"2017","journal-title":"Nat Rev Microbiol"},{"key":"10.1016\/j.jcf.2026.04.011_bib0013","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1038\/nm.3444","article-title":"Gut microbiota metabolism of dietary fiber influences allergic airway disease and hematopoiesis","volume":"20","author":"Trompette","year":"2014","journal-title":"Nat Med"},{"key":"10.1016\/j.jcf.2026.04.011_bib0014","doi-asserted-by":"crossref","DOI":"10.1016\/j.cell.2019.01.041","article-title":"Human anti-fungal Th17 immunity and pathology rely on cross-reactivity against Candida albicans","volume":"176","author":"Bacher","year":"2019","journal-title":"Cell"},{"key":"10.1016\/j.jcf.2026.04.011_bib0015","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.1111\/j.1572-0241.2001.03748.x","article-title":"Respiratory symptoms and pulmonary functional changes in patients with irritable bowel syndrome","volume":"96","author":"Yazar","year":"2001","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.jcf.2026.04.011_bib0016","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1038\/mi.2011.55","article-title":"Pulmonary-intestinal cross-talk in mucosal inflammatory disease","volume":"5","author":"Keely","year":"2012","journal-title":"Mucosal Immunol"},{"key":"10.1016\/j.jcf.2026.04.011_bib0017","doi-asserted-by":"crossref","first-page":"6794","DOI":"10.3748\/wjg.v19.i40.6794","article-title":"Gut-lung crosstalk in pulmonary involvement with inflammatory bowel diseases","volume":"19","author":"Wang","year":"2013","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.jcf.2026.04.011_bib0018","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1038\/embor.2012.32","article-title":"Early life antibiotic-driven changes in microbiota enhance susceptibility to allergic asthma","volume":"13","author":"Russell","year":"2012","journal-title":"EMBO Rep"},{"key":"10.1016\/j.jcf.2026.04.011_bib0019","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1067\/mai.2001.111237","article-title":"Distinct patterns of neonatal gut microflora in infants in whom atopy was and was not developing","volume":"107","author":"Kalliom\u00e4ki","year":"2001","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jcf.2026.04.011_bib0020","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1038\/nm.4176","article-title":"Neonatal gut microbiota associates with childhood multisensitized atopy and T cell differentiation","volume":"22","author":"Fujimura","year":"2016","journal-title":"Nat Med"},{"key":"10.1016\/j.jcf.2026.04.011_bib0021","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2024.1386428","article-title":"Heat-killed Akkermansia muciniphila ameliorates allergic airway inflammation in mice","volume":"15","author":"Yoon","year":"2024","journal-title":"Front Microbiol"},{"key":"10.1016\/j.jcf.2026.04.011_bib0022","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1038\/ni.3052","article-title":"The development and function of lung-resident macrophages and dendritic cells","volume":"16","author":"Kopf","year":"2015","journal-title":"Nat Immunol"},{"key":"10.1016\/j.jcf.2026.04.011_bib0023","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1183\/09031936.00079414","article-title":"Increased incidence of inflammatory bowel disease in Qu\u00e9bec residents with airway diseases","volume":"45","author":"Brassard","year":"2015","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jcf.2026.04.011_bib0024","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1378\/chest.13-0584","article-title":"Disturbed intestinal integrity in patients with COPD: effects of activities of daily living","volume":"145","author":"Rutten","year":"2014","journal-title":"Chest"},{"key":"10.1016\/j.jcf.2026.04.011_bib0025","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1378\/chest.14-0285","article-title":"GI symptoms in patients with COPD","volume":"145","author":"Rutten","year":"2014","journal-title":"Chest"},{"key":"10.1016\/j.jcf.2026.04.011_bib0026","doi-asserted-by":"crossref","first-page":"5886","DOI":"10.1038\/s41467-020-19701-0","article-title":"Disease-associated gut microbiome and metabolome changes in patients with chronic obstructive pulmonary disease","volume":"11","author":"Bowerman","year":"2020","journal-title":"Nat Commun"},{"key":"10.1016\/j.jcf.2026.04.011_bib0027","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1186\/s12931-021-01872-z","article-title":"Gut microbiota dysbiosis contributes to the development of chronic obstructive pulmonary disease","volume":"22","author":"Li","year":"2021","journal-title":"Respir Res"},{"key":"10.1016\/j.jcf.2026.04.011_bib0028","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1186\/s12931-019-1085-z","article-title":"Airway host-microbiome interactions in chronic obstructive pulmonary disease","volume":"20","author":"Wang","year":"2019","journal-title":"Respir Res"},{"key":"10.1016\/j.jcf.2026.04.011_bib0029","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0047305","article-title":"The lung microbiome in moderate and severe chronic obstructive pulmonary disease","volume":"7","author":"Pragman","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.jcf.2026.04.011_bib0030","doi-asserted-by":"crossref","DOI":"10.1016\/S2666-5247(21)00035-5","article-title":"Lung microbiome composition and bronchial epithelial gene expression in patients with COPD versus healthy individuals: a bacterial 16S rRNA gene sequencing and host transcriptomic analysis","volume":"2","author":"Ramsheh","year":"2021","journal-title":"Lancet Microbe"},{"key":"10.1016\/j.jcf.2026.04.011_bib0031","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.94040","article-title":"Chronic cigarette smoke exposure induces systemic hypoxia that drives intestinal dysfunction","volume":"3","author":"Fricker","year":"2018","journal-title":"JCI Insight"},{"key":"10.1016\/j.jcf.2026.04.011_bib0032","doi-asserted-by":"crossref","first-page":"2144","DOI":"10.3389\/fimmu.2020.02144","article-title":"Links between inflammatory bowel disease and chronic obstructive pulmonary disease","volume":"11","author":"Raftery","year":"2020","journal-title":"Front Immunol"},{"key":"10.1016\/j.jcf.2026.04.011_bib0033","doi-asserted-by":"crossref","DOI":"10.1128\/JB.00311-21","article-title":"The gut-lung axis in Cystic fibrosis","volume":"203","author":"Price","year":"2021","journal-title":"J Bacteriol"},{"key":"10.1016\/j.jcf.2026.04.011_bib0034","doi-asserted-by":"crossref","first-page":"6322","DOI":"10.3748\/wjg.v26.i41.6322","article-title":"Focus on gastroesophageal reflux disease in patients with cystic fibrosis","volume":"26","author":"Bongiovanni","year":"2020","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.jcf.2026.04.011_bib0035","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1186\/s40168-023-01543-9","article-title":"Detection of bile acids in bronchoalveolar lavage fluid defines the inflammatory and microbial landscape of the lower airways in infants with cystic fibrosis","volume":"11","author":"Caparr\u00f3s-Mart\u00edn","year":"2023","journal-title":"Microbiome"},{"key":"10.1016\/j.jcf.2026.04.011_bib0036","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.pedneo.2018.07.001","article-title":"Vitamin D status correlates with the markers of cystic fibrosis-related pulmonary disease","volume":"60","author":"Wani","year":"2019","journal-title":"Pediatr Neonatol"},{"key":"10.1016\/j.jcf.2026.04.011_bib0037","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1097\/MPG.0000000000002126","article-title":"Increasing vitamin D serum levels is associated with reduced pulmonary exacerbations in patients with cystic fibrosis","volume":"68","author":"Abu-Fraiha","year":"2019","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"10.1016\/j.jcf.2026.04.011_bib0038","doi-asserted-by":"crossref","DOI":"10.1016\/j.jcf.2026.01.002","article-title":"Children with cystic fibrosis have an early-life disparity in fecal short chain fatty acid concentrations","author":"Van Dorst","year":"2026","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.jcf.2026.04.011_bib0039","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1183\/09031936.00143614","article-title":"Short-chain fatty acids affect cystic fibrosis airway inflammation and bacterial growth","volume":"46","author":"Ghorbani","year":"2015","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jcf.2026.04.011_bib0040","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1008251","article-title":"CFTR dysregulation drives active selection of the gut microbiome","volume":"16","author":"Meeker","year":"2020","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.jcf.2026.04.011_bib0041","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1016\/j.jcf.2023.01.013","article-title":"The gut microbiome, short chain fatty acids, and related metabolites in cystic fibrosis patients with and without colonic adenomas","volume":"22","author":"Baldwin-Hunter","year":"2023","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.jcf.2026.04.011_bib0042","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.00251-12","article-title":"Serial analysis of the gut and respiratory microbiome in cystic fibrosis in infancy: interaction between intestinal and respiratory tracts and impact of nutritional exposures","volume":"3","author":"Madan","year":"2012","journal-title":"mBio"},{"key":"10.1016\/j.jcf.2026.04.011_bib0043","doi-asserted-by":"crossref","DOI":"10.1016\/j.jpeds.2015.02.049","article-title":"Associations between gut microbial colonization in early life and Respiratory outcomes in cystic fibrosis","volume":"167","author":"Hoen","year":"2015","journal-title":"J Pediatr"},{"key":"10.1016\/j.jcf.2026.04.011_bib0044","doi-asserted-by":"crossref","DOI":"10.1038\/srep24857","article-title":"Disrupted progression of the intestinal microbiota with age in children with cystic fibrosis","volume":"6","author":"Nielsen","year":"2016","journal-title":"Sci Rep"},{"key":"10.1016\/j.jcf.2026.04.011_bib0045","doi-asserted-by":"crossref","DOI":"10.1038\/srep26985","article-title":"Microbiological profiles of sputum and gastric juice aspirates in Cystic Fibrosis patients","volume":"6","author":"Al-momani","year":"2016","journal-title":"Sci Rep"},{"key":"10.1016\/j.jcf.2026.04.011_bib0046","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1186\/s12866-017-0968-8","article-title":"The altered gut microbiota in adults with cystic fibrosis","volume":"17","author":"Burke","year":"2017","journal-title":"BMC Microbiol"},{"key":"10.1016\/j.jcf.2026.04.011_bib0047","article-title":"Gut\u2013lung microbial dynamics with lumacaftor\/ivacaftor in children with cystic fibrosis: a prospective multicenter study","author":"Lussac-Sorton","year":"2025","journal-title":"Pediatr Res"},{"key":"10.1016\/j.jcf.2026.04.011_bib0048","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-025-64218-z","article-title":"CFTR modulator therapy drives microbiome restructuring through improved host physiology in cystic fibrosis: the IMMProveCF phase IV trial","volume":"16","author":"Knoll","year":"2025","journal-title":"Nat Commun"},{"key":"10.1016\/j.jcf.2026.04.011_bib0049","article-title":"Role of the microbiota-gut-lung axis in the pathogenesis of pulmonary disease in children and novel therapeutic strategies","volume":"16","author":"Wang","year":"2025","journal-title":"Front Immunol"},{"key":"10.1016\/j.jcf.2026.04.011_bib0050","article-title":"Longitudinal microbial and molecular dynamics in the cystic fibrosis lung after elexacaftor-tezacaftor-ivacaftor therapy","author":"Martin","year":"2023","journal-title":"Res Sq"},{"key":"10.1016\/j.jcf.2026.04.011_bib0051","doi-asserted-by":"crossref","DOI":"10.1016\/j.jcf.2026.05.003","article-title":"The gut microbiome: recent findings and future opportunities in cystic fibrosis","author":"Marsh","year":"2026","journal-title":"J Cyst Fibros: Off J Eur Cyst Fibros Soc"},{"key":"10.1016\/j.jcf.2026.04.011_bib0052","doi-asserted-by":"crossref","first-page":"350","DOI":"10.3390\/jpm11050350","article-title":"Individual and group response of treatment with ivacaftor on airway and gut microbiota in people with CF and a S1251N mutation","volume":"11","author":"Kristensen","year":"2021","journal-title":"J Pers Med"},{"key":"10.1016\/j.jcf.2026.04.011_bib0053","first-page":"54","article-title":"Cystic fibrosis liver disease in the new era of cystic fibrosis transmembrane conductance regulator (CFTR) modulators","volume":"50","author":"Eldredge","year":"2024","journal-title":"Paediatr Respir Rev"},{"key":"10.1016\/j.jcf.2026.04.011_bib0054","doi-asserted-by":"crossref","first-page":"3148","DOI":"10.1002\/ppul.27229","article-title":"A review of proton pump inhibitor use in cystic fibrosis and considerations for deprescribing","volume":"59","author":"Omecene","year":"2024","journal-title":"Pediatr Pulmonol"},{"key":"10.1016\/j.jcf.2026.04.011_bib0055","first-page":"16","article-title":"Clostridium difficile and cystic fibrosis: management strategies and the role of faecal transplantation","volume":"26","author":"Dunwoody","year":"2018","journal-title":"Paediatr Respir Rev"},{"key":"10.1016\/j.jcf.2026.04.011_bib0056","doi-asserted-by":"crossref","DOI":"10.1002\/ppul.71214","article-title":"Disorders of gut-brain interaction in a pediatric cystic fibrosis cohort","volume":"60","author":"Smith","year":"2025","journal-title":"Pediatr Pulmonol"},{"key":"10.1016\/j.jcf.2026.04.011_bib0057","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/s40348-025-00194-0","article-title":"Progress of personalized medicine of cystic fibrosis in the times of efficient CFTR modulators","volume":"12","author":"T\u00fcmmler","year":"2025","journal-title":"Mol Cell Pediatr"}],"container-title":["Journal of Cystic Fibrosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1569199326001049?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1569199326001049?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T04:21:50Z","timestamp":1783052510000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1569199326001049"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":57,"alternative-id":["S1569199326001049"],"URL":"https:\/\/doi.org\/10.1016\/j.jcf.2026.04.011","relation":{},"ISSN":["1569-1993"],"issn-type":[{"value":"1569-1993","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Towards a gut-lung axis role in pwCF on CFTR modulators: rationale, clinical evidence and perspectives","name":"articletitle","label":"Article Title"},{"value":"Journal of Cystic Fibrosis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jcf.2026.04.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 European Cystic Fibrosis Society. Published by Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}